Indaptus Historical Cash Flow
| INDP Stock | USD 0.95 0.03 3.26% |
Analysis of Indaptus Therapeutics cash flow over time is an excellent tool to project Indaptus Therapeutics future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Net Borrowings of 777.2 K or Stock Based Compensation of 3.6 M as it is a great indicator of Indaptus Therapeutics ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Indaptus Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Indaptus Therapeutics is a good buy for the upcoming year.
Indaptus |
About Indaptus Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Indaptus balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Indaptus's non-liquid assets can be easily converted into cash.
Indaptus Therapeutics Cash Flow Chart
Add Fundamental
Net Borrowings
The difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Indaptus Therapeutics to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Indaptus Therapeutics operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Indaptus Therapeutics' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Indaptus Therapeutics current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Indaptus Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. To learn how to invest in Indaptus Stock, please use our How to Invest in Indaptus Therapeutics guide.At this time, Indaptus Therapeutics' Investments are relatively stable compared to the past year. As of 01/31/2025, Change In Cash is likely to grow to about 4.5 M, though Total Cashflows From Investing Activities is likely to grow to (14 M).
| 2024 | 2025 (projected) | Stock Based Compensation | 3.4M | 3.6M | Net Borrowings | 1.3M | 777.2K |
Indaptus Therapeutics cash flow statement Correlations
Click cells to compare fundamentals
Indaptus Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Indaptus Therapeutics cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | (2.2M) | 37.5M | (29.5M) | 3.7M | 4.3M | 4.5M | |
| Stock Based Compensation | 140.0K | 1.5M | 3.0M | 3.0M | 3.4M | 3.6M | |
| Free Cash Flow | (3.3M) | (11.3M) | (13.3M) | (13.4M) | (15.4M) | (16.2M) | |
| Change In Working Capital | 118.7K | (5.1M) | (1.6M) | (518.1K) | (466.3K) | (489.6K) | |
| Begin Period Cash Flow | 3.8M | 1.6M | 39.1M | 9.6M | 8.7M | 15.0M | |
| Other Cashflows From Financing Activities | 1.2M | 43.3M | (16.4M) | 17.1M | 19.7M | 10.0M | |
| Depreciation | 852.0 | 1.4K | 1.8K | 1.3K | 1.2K | 1.1K | |
| Other Non Cash Items | (3.4M) | 5.7M | (134.2K) | (431.0K) | (387.9K) | (368.5K) | |
| Total Cash From Operating Activities | (3.3M) | (11.3M) | (13.1M) | (13.4M) | (15.4M) | (16.2M) | |
| Net Income | (3.6M) | (7.7M) | (14.3M) | (15.4M) | (17.7M) | (18.6M) | |
| End Period Cash Flow | 1.6M | 39.1M | 9.6M | 13.4M | 15.4M | 16.1M |
Pair Trading with Indaptus Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Indaptus Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Indaptus Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Indaptus Stock
Moving against Indaptus Stock
| 0.61 | ALTS | ALT5 Sigma Symbol Change | PairCorr |
| 0.58 | BMY | Bristol Myers Squibb Earnings Call This Week | PairCorr |
| 0.55 | EHAB | Enhabit | PairCorr |
| 0.47 | GILD | Gilead Sciences Earnings Call This Week | PairCorr |
| 0.47 | LFCR | Lifecore Biomedical | PairCorr |
The ability to find closely correlated positions to Indaptus Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Indaptus Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Indaptus Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Indaptus Therapeutics to buy it.
The correlation of Indaptus Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Indaptus Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Indaptus Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Indaptus Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Indaptus Stock Analysis
When running Indaptus Therapeutics' price analysis, check to measure Indaptus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Indaptus Therapeutics is operating at the current time. Most of Indaptus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Indaptus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Indaptus Therapeutics' price. Additionally, you may evaluate how the addition of Indaptus Therapeutics to your portfolios can decrease your overall portfolio volatility.